Literature DB >> 7185954

Epidemiology of meningococcal meningitis in Belgium.

S De Maeyer, J M Seba, G Reginster.   

Abstract

The results of a sero-epidemiological study of an outbreak of meningococcal disease in Belgium are reported. This epidemic, which commenced in 1969, reached its peak incidence (five cases per 100 000 of the population) in 1971 and 1972. Thereafter the incidence of disease decreased and, currently, has fallen to normal inter-epidemic proportions (one case per 100 000 of the population per year). The epidemic was caused by Neisseria meningitidis serogroup B, serotype 2 being principally involved. The prevalence of serotype 2 amongst patients fell during the transition from epidemic to non-epidemic periods, but the difference was not statistically significant. How ever, amongst carriers the low prevalence of this serotype decreased significantly during the transition period. Serotype 2 was thus strongly associated with this epidemic of meningococcal disease. The influence of carriage of this serotype on the incidence of clinical disease cannot be precisely determined. However, a direct relationship appears probable.

Entities:  

Mesh:

Year:  1981        PMID: 7185954     DOI: 10.1016/s0163-4453(81)80010-2

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  8 in total

1.  Filter radioimmunoassay, a method for large-scale serotyping of Neisseria meningitidis.

Authors:  S de Marie; J H Hoeijmakers; J T Poolman; H C Zanen
Journal:  J Clin Microbiol       Date:  1984-08       Impact factor: 5.948

2.  Distribution of serotypes of Neisseria meningitidis in the Federal Republic of Germany, 1979-1981.

Authors:  U Berger
Journal:  Med Microbiol Immunol       Date:  1982       Impact factor: 3.402

3.  Development of a Neisseria meningitidis group B serotype 2b protein vaccine and evaluation in a mouse model.

Authors:  L Y Wang; C E Frasch
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

4.  Carriage of Neisseria meningitidis and Neisseria lactamica in a school population during an epidemic period in Spain.

Authors:  J A Saez-Nieto; J R Dominguez; J L Monton; P Cristobal; A Fenoll; J Vazquez; J Casal; B Taracena
Journal:  J Hyg (Lond)       Date:  1985-06

5.  Protection against group B Neisseria meningitidis disease: preparation of soluble protein and protein-polysaccharide immunogens.

Authors:  C E Frasch; M S Peppler
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

6.  Strains of Neisseria meningitidis isolated from patients and their close contacts.

Authors:  C E Frasch; L F Mocca
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

7.  Immunogenicity and side-effects of a new tetravalent meningococcal polysaccharide vaccine.

Authors:  F Ambrosch; G Wiedermann; P Crooy; A M George
Journal:  Bull World Health Organ       Date:  1983       Impact factor: 9.408

8.  Changes in Meningococcal Strains in the Era of a Serogroup C Vaccination Campaign: Trends and Evolution in Belgium during the Period 1997-2012.

Authors:  Wesley Mattheus; Germaine Hanquet; Jean-Marc Collard; Raymond Vanhoof; Sophie Bertrand
Journal:  PLoS One       Date:  2015-10-01       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.